Operating Lease, Right-of-Use Asset of 10x Genomics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
10x Genomics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • 10x Genomics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $63,650,000, a 6.8% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

10x Genomics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $63,650,000 +$4,071,000 +6.8% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $62,700,000 +$1,828,000 +3% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $55,577,000 -$7,273,000 -12% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $57,290,000 -$8,071,000 -12% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $59,579,000 -$9,613,000 -14% 30 Sep 2024 10-Q 29 Oct 2024 2024 Q3
Q2 2024 $60,872,000 -$10,177,000 -14% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $62,850,000 -$11,888,000 -16% 31 Mar 2024 10-Q 30 Apr 2024 2024 Q1
Q4 2023 $65,361,000 -$4,521,000 -6.5% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $69,192,000 -$1,903,000 -2.7% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $71,049,000 -$2,376,000 -3.2% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $74,738,000 -$942,000 -1.2% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $69,882,000 +$8,964,000 +15% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $71,095,000 +$10,380,000 +17% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $73,425,000 +$19,300,000 +36% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $75,680,000 +$19,327,000 +34% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $60,918,000 +$13,935,000 +30% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $60,715,000 +$15,336,000 +34% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $54,125,000 +$10,988,000 +25% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $56,353,000 +$12,305,000 +28% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $46,983,000 +$46,983,000 31 Dec 2020 10-K 18 Feb 2022 2021 FY
Q3 2020 $45,379,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 $43,137,000 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $44,048,000 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $0 31 Dec 2019 10-Q 12 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.